Trial site
Montreal
- 8running trials
- 5closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- High blood pressure3 trials
- Alzheimer disease2 trials
- Acute myeloid leukaemia1 trial
- Amyloidosis1 trial
- Childhood cancers1 trial
- Chronic kidney disease1 trial
- Huntington's disease1 trial
- Metastatic breast cancer1 trial
- Myasthenia gravis1 trial
- Obesity1 trial
- Prostate cancer1 trial
- Type 1 diabetes1 trial
- and 1 more
- Phase
- Phase 14 trials
- Phase 34 trials
- Phase 23 trials
- Phase 1/21 trial
- Status
- Recruiting6 trials
- Completed4 trials
- Active, not recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Alnylam Pharmaceuticals9 trials
- Alexion Pharmaceuticals, Inc.1 trial
- Arvinas Androgen Receptor, Inc.1 trial
- Olema Pharmaceuticals, Inc.1 trial
- Syndax Pharmaceuticals1 trial
Running trials
Recruiting
Recruiting
A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
Recruiting
Recruiting
A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease
Active, not recruiting
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy
Active, not recruiting
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Recruiting
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- Acute myeloid leukaemia1 recruiting
- Childhood cancers1 recruiting
- High blood pressure1 recruiting
- Huntington's disease1 recruiting
- Myasthenia gravis1 recruiting
Closed trials
Completed
Terminated
Completed
Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer
Completed
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026